The Medicines (NASDAQ:MDCO) reported Q4 2017 earnings this Morning, coming in at ($2.19) per share, missing Wall Street’s estimates of ($1.48) per Share. Revenue for the quarter came in at $8.60 million beating analyst estimates of $20.71 million Recent Insider Trading for The Medicines (NASDAQ:MDCO)
- On 12/15/2017 Clive Meanwell, CEO, sold 136,250 with an average share price of $27.24 per share and the total transaction amounting to $3,711,450.00.
- On 12/8/2017 Fredric N Eshelman, Insider, bought 200,000 with an average share price of $26.56 per share and the total transaction amounting to $5,312,000.00.
- On 11/29/2017 Alexander J Denner, Director, bought 170,000 with an average share price of $30.03 per share and the total transaction amounting to $5,105,100.00.
- On 2/7/2017 William Bernard O’connor, CFO, sold 25,833 with an average share price of $46.20 per share and the total transaction amounting to $1,193,484.60.
- On 12/8/2016 Christopher T Cox, EVP, bought 105,500 with an average share price of $33.20 per share and the total transaction amounting to $3,502,600.00.
- On 12/8/2016 Fredric N Eshelman, Director, bought 621,720 with an average share price of $33.77 per share and the total transaction amounting to $20,995,484.40.
Recent Trading for The Medicines (NASDAQ:MDCO) Shares of The Medicines closed the previous trading session at 32.05 down -0.75 2.29% with 31.700000762939453 shares trading hands.